Genoderm Flashcards
Epidermolytic ichthyosis - genes
KRT1
KRT10 - no hands
Ichthyosis vulgaris - gene
FLG/ profillagrin
Semi autosomal dominant
Steroid sulfurase deficiency - gene
X linked recessive
STS gene deletion of Xp22.31
Gene associated with pilomatricoma and carcinoma
CTNNB1
Langerhanscell histiocytosis gene
BRAFV600E
Diagnostic criteria for NF1
CANFOOL Cafe au lait macules - >6, >5 mm pre-pubertal or >15 mm post Axillary freckling Neurofibromas - X2 any, X 1 plexiform First degree relative Osseus lesions Optic gliomas Lischn nodules
Epidermal naevus epidemiology
1 in 1000 infants
Epidermal naevus clinical features
- 80% occur within first year of life
- Most commonly single linear
- Well circumscribed, hyperpigmented papillomatous papules or plaques
- Asymptomatic
- Rarely - hypopigmented
- Can thicken and become more verrucous - particularly over joints
Rarely - malignant change, if so will be post-puberty - Location: commonly trunk and neck, follows lines of Blaschko
- Naevus verrucosus: warty appearance
- Naevus unius lateris: extensive, unilateral plaques, often involving the trunk
- Ichthyosis hystrix: extensive bilateral involvement, also on the trunk
- Epidermal naevus syndrome: epidermal naevi with other anomalies - CNS, MSK
Epidermal naevus pathogenesis (genes and what is it)
- Thought to originate from pluripotent cells in the basal layer of the embryonic epidermis, harmatomous process involves epidermis and at least some of papillary dwermis
- Possible mutations:
- Mutations identified in some: KRT1, KRT10, ATP2A2
- Common: FGFR3 mosaicism for activating mutations
- Have also found PIK3CA mutation
- RAS mutations have been observed in patients with keratinocytic epidermal naevi (HRAS>NRAS>KRAS)
Epidermal naevus histology
- epidermal hyperplasia
- hyperkeratosis
- acanthosis
- papillomatosis
- variable parakeratosis
- focal acantholytic dyskeratosis
Ddx epidermal naevus
- Naevus sebaceous
- Organoid naevi
- Lichen striatus
- Linear and whorled naevoid hypermelanosis
- Porokeratotic eccrine ostial and dermal duct naevus
- Linear LP
- X-linked dominant chondrodysplasia punctata
Treatment epidermal naevus
- Full thickness excision: recurrence is common, and can be complicated by scarring
- Topical therapies with limited benefit: steroids, retinoic acid, tars, anthralin, 5-FU, podophyllin
- Systemic therapy: retinoids –> decreases thickness
- Laser ablation –> however to be effective must induce scarring
PWS/Sturge Weber mode of inheritance and gene
GNAQ –> Q class G protein alpha subunits
Mosaic, with somatic mutations in lesional skin
Activating mutation
PWS/Phakomatosis pigmentovascularis type 2 or overgrwoth of an extremity
GNA11 –> Q class G protein alpha sub units
Mosaic, with somatic mutations in lesional skin
Activating mutation
Ataxia telangiectasia genetics
ATM gene - ATM protein is similar to phosphoinositol 3 kinase - regulates cell cycle, DNA repair, p53
Autosomal recessive
Loss of function
Capillary malformation-AVM genetics
RASA1 and EPHB4
loss of function - p120-Ras-GAP protein and EPH receptor B4 in endothelial cells - interact and modulate MAPK signaling growth factor receptors
Autosomal dominant
Cutaneous and mucosal venous malformations and Blue rubber bleb naevus syndrome genetics
TEK
Gain of function of TIE-2 - an endothelial cell-specific tyrosine kinase receptor that binds angiopoietins
Auutosomal dominant
Blue rubber bleb is mosaic
Venous malformations genetics
TEK, PIK3CA
Gain of function of TIE-2 –> binds angiopoietins
PIK3CA - activates the AKT/mTOR pathway
Lymphatic malformations genetics
PIK3CA - gain of function
TIE2 –> binds angiopoietins
PIK3CA activates the AKT/mTOR pathway
Mosaic, with somatic mutations in lesional tissue
Hereditary lymphoedema genetics
GJC2
Loss of function: connexin 47 in gap junctions of lymphatic vessels
autosomal dominant
CADASIL genetics
NOTCH3
Accumulation of NOTCH-3 protein in vascular smooth muscle cells
Phakomatosis pigmentovascularis 1
Epidermal naevus + port wine stain
<5% of PPV cases